The Impact Africa Summit (IAS) a brainchild of Nigeria’s foremost contract research organization is designed to initiate strategic interactions and forge collaborations for excellence within the clinical research industry for Africa. The goal of the Impact Africa Summit is to build a network of industry experts and stakeholders to help achieve sustainable capacity for pharmaceutical […]
Early research findings from Fitbit show that physiological signs of disease can be detected by wearable devices simultaneously with individuals reporting the onset of COVID-19 symptoms, and in some cases even before Fitbit has released findings from a recent study showing that its wearable device can detect nearly 50 percent of COVID-19 cases one day
Could Wearables Detect COVID-19 Before Symptoms Appear? Read More »
Researchers have designed and tested a protein that may lead to a therapeutic for COVID-19. A novel receptor protein that binds to the SARS-CoV-2 virus and prevents it from entering cells may hold promise for treating COVID-19 and other coronavirus-related diseases, according to research published online Aug. 4 in the journal SCIENCE. As scientists race
From a long-standing brick-and-mortar model, the healthcare system adopts more virtual care, deepening focus on patient-centricity and engagement. After many months of the enduring pandemic, taking a brief respite to reflect on the changes that have occurred, and which ones will change the way healthcare is practiced and delivered, is imperative to continue to grow
Why aren’t children included in most COVID-19 Trials? There are several reasons why children are widely excluded from current COVID-19 studies. In general, pediatric studies present more challenges than traditional adult studies. For starters, there are simply fewer patients to recruit. The pediatric population makes up only about 17% of the world population, and pediatric
